What we do
The EIF in 2020
Coronavirus: The EIB Group’s initiatives to address its economic consequences
Pan-European Guarantee Fund – EGF
Institutional investors
Equity products
AI Co-Investment Facility
Climate & Infrastructure Funds
Technology Transfer
European Angels Fund (EAF) - Co-investments with Business Angels
Venture capital
The Social Impact Accelerator (SIA)
Lower mid-market
Mezzanine Facility for Growth
EFSI Equity instrument
Single EU Equity Financial Instrument
COSME - Equity Facility for Growth
InnovFin Equity
Private equity secondary market transactions
EIF-NPI Equity Platform
ESCALAR Programme
Debt products
New ESIF ERDF Guarantee Fund initiative in Greece
EFSI Private Credit Programme
AGRI Guarantee Facility
AGRI Italy Platform Uncapped Guarantee Instrument
Credit enhancement
Cultural and Creative Sectors Guarantee Facility (CCS GF)
ENSI - Securitisation Initiative
Erasmus+ Master Loan Guarantee Facility
Skills & Education Guarantee Pilot
EREM debt products
Single EU Debt Financial Instrument
Documentary Finance Facility – Bulgaria
The SME Initiative
The SME Initiative Bulgaria
The SME Initiative Finland
The SME Initiative Italy
The SME Initiative Malta
The SME Initiative Romania
The SME Initiative Spain
Inclusive finance
EaSI Financial Instruments
EaSI Capacity Building Investments Window
EaSI Guarantee Instrument
EaSI Funded Instrument
European Progress Microfinance Facility
Entrepreneurs supported through Progress Microfinance
European Fund for Strategic Investments (EFSI)
How does EIF contribute to EFSI
How to apply for EFSI financing
Regional Development - Country and sector-specific initiatives
Fons d’Inversió en Tecnologia Avançada (FITA) Catalonia
Dutch Future Fund (DFF)
Dutch Alternative Credit Instrument (DACI)
PORTUGAL BLUE: a new initiative for blue economy investments
JEREMIE Greece Reflows – Business Angels’ Co-Investment Equity Instrument
German Corona Matching Facility (CMF)
Portugal Growth programme
Croatian Growth Investment Programme (CROGIP)
AGRI Italy Platform Uncapped Guarantee Instrument
ALTER’NA – ESIF EARFD Nouvelle-Aquitaine
Baltic Innovation Fund 1 (BIF 1)
Baltic Innovation Fund 2 (BIF 2)
Central Europe Fund of Funds (CEFoF)
Croatian Venture Capital Initiative (CVCi FoF)
Competitiveness Fund-of-Funds for SMEs in Romania
The Cyprus Entrepreneurship Fund (CYPEF)
Deep and Comprehensive Free Trade Area Initiative East Guarantee Facility (DCFTA)
Dutch Growth Co-Investment Programme
Dutch Venture Initiative (DVI-II)
ESIF Fund-of-Funds Greece
EAFRD FoF Portugal
EAFRD FoF Romania
The ERP-EIF Facility
ERP-EIF Co-Investment Growth Facility
The LfA-EIF Facilities
The German Future Fund (GFF) - EIF Growth Facility
INAF – French National Agricultural Initiative
ESIF Energy Efficiency and Renewable Energy Malta
Regional Fund-of-Funds Romania
ESIF Fund-of-Funds Czech Republic
The Silesia EIF Fund of Funds
La Financière Région Réunion
The EIB Group Risk Enhancement Mandate (EREM)
Greater Anatolia Guarantee Facility (GAGF)
G43 - Anatolian Venture Capital Fund Project
InvestBG Equity Instrument
Romania Recovery Equity Fund of Funds
JEREMIE Romania Reflows – Equity Instrument
Luxembourg Future Fund (LFF)
Mezzanine 'Fund of Fund' for Germany (MDD)
Polish Growth Fund of Funds (PGFF)
Portugal Venture Capital Initiative (PVCi)
Scottish-European Growth Co-Investment Programme
Slovene Equity Growth Investment Programme (SEGIP)
Swedish Venture Initiative (SVI)
Turkish Growth and Innovation Fund (TGIF)
Western Balkans Enterprise Development & Innovation Facility (WB EDIF)
EAFRD FoF Greece
Irish Innovation Seed Fund (IISF)

How EFSI benefits SMEs in Europe - Innovation Nest case study: Doctrina (Slovenia), ICT


In many industries, scientific developments can make a big difference from one day to the next. The pharmaceutical industry is a prime example. “We believe that keeping knowledge up to date is crucial for professional development, so we wanted to make it accessible to anyone, anytime and anywhere,” says Tomaž Erjavec, CEO of Doctrina. “When it comes to the latest pharmaceutical products, representatives of pharmaceutical companies try to visit health professionals and personally convey the latest information. But they only have limited penetration into the market. They can reach - at best - an estimated 30% of health professionals. At a pharmacy for example, they’ll be talking to the manager but not all the staff, right? And it’s also incredibly awkward if they need to jump a queue to talk to a doctor while patients have to wait outside,” explains Tomaž, who set up Doctrina with his business partner Jure Pučko, both leveraging off their prior experience working in the pharmaceutical industry.

Doctrina offers online education to pharmacists, specialist retailers, doctors and other healthcare professionals through interactive video courses. “Each video is about eight minutes long and the key thing is that they can watch it and get all the relevant information about a product whenever it suits them. When it comes to sales visits from the representatives of pharmaceutical companies, 90% of the time ‘is not a good time’. Health professionals are busy people. By using videos, we overcome this problem,” Tomaž says. “The approach is less costly, more efficient and ultimately more effective.”

In mid-2017, Doctrina received an important equity investment from Innovation Nest, a venture capital firm backed by the EIF under the EU’s Investment Plan for Europe. “It helped us to scale-up the business,” explains Tomaž, “expand to new countries, strengthen our marketing department, develop the products…But equally important was the advice, the ‘smart money’, because through Innovation Nest, we got access to their network of contacts, and to advice on all issues pertaining to running a business. They gave us a helicopter view with their ten years of experience. The boost is more than just the money.”

With clients including the big pharmaceutical companies like Pfizer and GSK, Doctrina is growing fast. But it’s not all about sales, as Tomaž points out: “Throughout this process, I basically learned that I knew nothing. So in this business we keep our ears open. We try to close the feedback loop – hearing what the healthcare professionals think, what they want more of, what their needs are… Two-way communication is key.”

Company: Doctrina (Slovenia)

Type of business: ICT

EIF financing: InnovFin Equity, EFSI

Financial intermediary: Innovation Nest

For further information about EIF intermediaries in Spain, please refer to: http://www.eif.org/what_we_do/where/sl


We use cookies to give the best browser experience on our website. or change cookie settings.

Note: Following the recent withdrawal of the United Kingdom from the European Union, we are updating the relevant EIF.org pages.


Copyright ©

 European Investment Fund   – The European Investment Fund is not responsible for the content of external internet sites.